NMS Labs Responds to National Health Concerns with Its Groundbreaking Test to Monitor Bisphenol-A (BPA) Levels in Humans
1/26/2010 10:59:58 AM
WILLOW GROVE, Pa.--(BUSINESS WIRE)--NMS Labs launches its groundbreaking test that will allow medical researchers, health care, occupational and environmental medicine practitioners to accurately measure Bisphenol-A (BPA) in their patients. This is a timely release due to the FDA’s recent reversal of its position on BPA’s potentially harmful effects and the National Toxicology Program’s (NTP) official position. Researchers funded by the American Recovery and Reinvestment Act administered by the National Institute of Environmental Health Sciences (NIEHS)/National Institutes of Health (NIH) continue to investigate toxicity concerns of BPA.